{"slug":"entities","open_questions":[{"id":"open_question-entities-pc12-cell-line-f1dc1cd8","title":"iPSC comparison","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-pc12-cell-line-ab4e1543","title":"3D culture systems","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-pc12-cell-line-c86ceb2d","title":"CRISPR screening","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-remternetug-d9ff1b81","title":"Subcutaneous formulation:","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-remternetug-ea0979b7","title":"Fixed-dose regimen:","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-remternetug-b34721d5","title":"Biannual dosing:","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-ae8f9089","title":"Biomarker-driven selection","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-836085b7","title":"Genetic stratification","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-e7904cbd","title":"Disease stage optimization","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-07030245","title":"Multiple antibodies","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-bf1df157","title":"Small molecules","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-e3ca0ff5","title":"Cell replacement","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-88564b05","title":"Symptomatic drugs","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-16a35d41","title":"Clinical endpoints","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-59194947","title":"Biomarker endpoints","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-132a773b","title":"Digital biomarkers","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-prasinezumab-66cb274d","title":"Composite endpoints","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-bnip1-protein-dcfd3a45","title":"Cell type-specific functions","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-bnip1-protein-af249cb1","title":"Post-translational modifications","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5},{"id":"open_question-entities-pc12-cell-line-ad8d0a53","title":"Microfluidic platforms","importance_elo":1500,"status":"open","potential_impact_score":0.5,"tractability_score":0.5}],"open_questions_total":20,"knowledge_gaps":[],"gap_count":0,"landscape":null,"hypothesis_count":0,"personas":[{"id":"christof-koch","name":"Christof Koch","type":"debater","icon":"🌀","color":"#5c6bc0","debate_count":1},{"id":"rui-costa","name":"Rui Costa","type":"debater","icon":"🏃","color":"#ef5350","debate_count":1},{"id":"xiaojun-li","name":"Xiaojun Li","type":"debater","icon":"🔬","color":"#8d6e63","debate_count":0},{"id":"pete-skene","name":"Pete Skene","type":"debater","icon":"🔬","color":"#8d6e63","debate_count":0},{"id":"ed-lein","name":"Ed Lein","type":"debater","icon":"🧠","color":"#4fc3f7","debate_count":0},{"id":"clinical_trialist","name":"Clinical Trialist","type":"reviewer","icon":"📋","color":"#4dd0e1","debate_count":0},{"id":"sud-pinglay","name":"Sud Pinglay","type":"debater","icon":"🧬","color":"#26a69a","debate_count":0},{"id":"jay-shendure","name":"Jay Shendure","type":"debater","icon":"🧪","color":"#ffa726","debate_count":0},{"id":"medicinal_chemist","name":"Medicinal Chemist","type":"builder","icon":"🧪","color":"#aed581","debate_count":0}]}